Celvivo appoints Jacob Philipsen as new CEO
Danish 3D cell culture company Celvivo has appointed Jacob Philipsen as CEO to lead its next phase of growth.
Philipsen joins from Advalight, where, as CEO, he helped scale the company from pre-revenue to sales in more than 50 countries. He has also served as CEO of RSP Systems and is a co-founder and chairman of Norlase, bringing a track record of taking early-stage companies through the kind of scale-up phase Celvivo is now entering.
Philipsen succeeds Peter Willems-Alnøe, who had led Celvivo since 2018; the board and Celvivo thank him for his contributions to building the technology and the team.
“Jacob has a proven track record of taking companies from early commercial traction to a global scale, which is exactly the phase Celvivo is entering. Combined with the backing from our investors and an even more experienced board, we now have the leadership and the capital to help execute on that next stage of Celvivo’s journey,” says Patrik Dahlen, Chairman of the Board.
“We operate in a rapidly developing market with large, untapped potential in the technologies presently being used. With this new leadership, we have a decisive opportunity to turn that potential into reality. It’s a strong vote of confidence as we enter the next stage of Celvivo’s growth and scale-up journey,” says Jacob Philipsen, CEO of Celvivo.
Updated: September 14, 2026, 08:44 am
Published: September 2, 2026
